Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Childhood Liver Disease Research Network (ChiLDReN): FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE) Study Protocol

NCT02922751 is registered in ClinicalTrials.gov with Arbor Research Collaborative for Health as lead sponsor.

NCT NCT02922751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02922751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Childhood Liver Disease Research Network (ChiLDReN): FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE) Study Protocol
Lead sponsor
Arbor Research Collaborative for Health
Phase
Observational
Overall status
Completed
Start date
November 16, 2016
Completion date
December 22, 2022
Enrollment
552 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

alagille syndrome, alpha1 anti-trypsin deficiency, biliary atresia, cholestasis, liver fibrosis, portal hypertension